🕒 Friday 25 July 2025 Fri, 25 July 2025

Neurizon Therapeutics has formally responded to the FDA's clinical hold on its lead ALS drug NUZ-001, submitting new animal safety data. The company aims to join the HEALEY ALS Platform Trial by late 2025, pending regulatory approval.

Metals X delivered its third highest quarterly tin production at Renison, improved cash flow, and expanded its strategic footprint with a $5 million investment in Elementos and a partial offer for Greentech shares.

Albion Resources has reported impressive near-surface gold intercepts at its Collavilla Prospect in Western Australia, highlighting a standout 11m at 20.0 g/t gold from just 17m depth. A detailed gravity survey is underway to pinpoint further high-grade targets within the expansive Ives Find granite.

WhiteHawk Limited has completed a A$2 million share placement aimed at advancing its AI and machine learning automation capabilities and supporting new US cyber governance contracts.

Paterson Resources has secured heritage clearance and reported promising metallurgical results at its Grace Gold-Copper Project, setting the stage for a significant drilling campaign to upgrade its resource estimate.

Kali Metals bolsters its Pilbara gold project with new tenement acquisitions and exceptional rock chip assays, setting the stage for its inaugural drilling campaign. The discovery of the Churchill Gold Prospect extends the mineralised corridor to nearly 3km.

Octava Minerals Limited has had its trading suspension lifted following the announcement of a proposed capital raising, signaling renewed market activity for the mining explorer.

Octava Minerals secures $1.5 million in a placement to fund exploration and due diligence for acquiring the historically promising Federation copper-zinc-silver project in Western Tasmania.

Orpheus Uranium has secured a Native Title Mining Agreement with the Wilyakali people, unlocking advanced exploration at its Radium Hill South and Mundaerno projects. This milestone sets the stage for drilling approvals expected by late 2025.

Fat Prophets Global Contrarian Fund reports a 5.06% rise in pre-tax NTA driven by gains in Japanese and Chinese markets, announcing a special dividend after years of pause.

Venus Metals Corporation has secured the mining lease for its Bellchambers gold deposit, unlocking the path toward advancing development with promising drilling results and planned resource updates.

Ambertech Limited anticipates surpassing $100 million in revenue for FY25, driven by a strong second half and improved profitability across key segments.

Aurum Resources reports exceptional high-grade gold intercepts at its Boundiali Gold Project in Côte d'Ivoire, underpinning an aggressive 100,000m drilling campaign and a Pre-Feasibility Study due by year-end.

Peako Limited halted field exploration in the June quarter due to seasonal and logistical challenges, surrendered two tenements, and announced the resignation of its CEO, while maintaining a solid cash position.

Tesoro Gold has reported promising drilling results expanding its Ternera gold resource and secured A$11.1 million in fresh capital, positioning the El Zorro project for accelerated development.

Tanami Gold NL has reported promising initial assay results from its latest drilling campaign at the historic Jims Gold Mine, revealing significant gold intercepts that hint at potential resource expansion. Final results from the majority of diamond core samples are still awaited, keeping the market’s attention.

Sierra Nevada Gold (ASX – SNX) has completed the purchase of the New Pass Gold Mine claims in Nevada, gaining 100% ownership and reporting promising gold grades in historic tailings. The company advances plans for bulk sampling and underground mining, while exploration at its Warrior project reveals new targets.

DeSoto Resources has ramped up exploration at its Northern Territory Spectrum Project, deploying a second drill rig and completing a significant deep hole at the Quantum Rare Earth Deposit.

Rapid Critical Metals has completed its acquisition of Silver Metal Group’s subsidiaries, marking a strategic expansion into silver, while appointing Byron Miles as its new Managing Director to steer the company’s next growth phase.

BlinkLab is advancing its FDA 510(k) clinical trials for autism and ADHD diagnostics, completing its U.S. autism pilot phase and expanding European ADHD recruitment. A recent $7.66 million capital raise supports these efforts as the company targets regulatory approvals in 2026.

FAR Limited reports robust production from Senegal’s Sangomar field and receives a provisional $11.5 million contingent payment, while addressing a $6 million indemnity claim from Woodside Energy.

Dimerix has secured a significant licensing agreement with Amicus Therapeutics for its kidney disease drug candidate DMX-200 in the US, receiving a US$30 million upfront payment and advancing its Phase 3 trial with FDA endorsement of a key clinical endpoint.

Stockland updates its interim dividend for the six months ending June 2025, confirming an estimated payout of AUD 0.172 per security and announcing the Dividend Reinvestment Plan price at AUD 5.43 with a 1% discount.

Whitehaven Coal has delivered a robust FY25 performance, exceeding production and cost guidance while managing market softness and advancing key projects.